BBS2 Antibodies

Santa Cruz Biotechnology delivers a wide array of BBS2 monoclonal antibodies for research in understanding Bardet-Biedl Syndrome and its associated pathways. BBS2 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BBS2, a member of the Bardet-Biedl syndrome gene family, plays a crucial role in ciliary function and cellular signaling. Mutations in the BBS2 gene are linked to the development of Bardet-Biedl Syndrome, a genetic disorder characterized by obesity, retinal degeneration, and polydactyly, among other symptoms. Understanding BBS2 function is essential for elucidating the molecular mechanisms underlying this syndrome and developing potential therapeutic strategies. Research focused on BBS2 continues to reveal new insights into cellular processes and disease mechanisms. Investigating BBS2 expression patterns helps identify its role in different tissues and developmental stages. Exploring BBS2 interactions with other proteins provides valuable information about cellular signaling networks. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance their studies and contribute meaningful discoveries to the scientific community's understanding of Bardet-Biedl Syndrome.